NTS2 modulates the intracellular distribution and trafficking of NTS1 via heterodimerization

Biochemical and Biophysical Research Communications

Volumn 353, Issue 3, 2007, Pages 582-590

  Perron, Amélie ^a   Sharif, Nadder ^a   Sarret, Philippe ^b   Stroh, Thomas ^a   Beaudet, Alain ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Cell surface; Dimerization; Down regulation; GPCRs; Internalization; Neurotensin; Trafficking

Indexed keywords

CELL SURFACE RECEPTOR; HETERODIMER; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTENSIN; NEUROTENSIN 1; NEUROTENSIN 2; NEUROTENSIN RECEPTOR; RADIOLIGAND; UNCLASSIFIED DRUG;

ARTICLE; CELL DENSITY; CELL STRAIN COS7; CELL SURFACE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; DIMERIZATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERNALIZATION; LIGAND BINDING; MAMMAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; WESTERN BLOTTING;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DIMERIZATION; DOWN-REGULATION; MAP KINASE SIGNALING SYSTEM; MICROSCOPY, CONFOCAL; PROTEIN TRANSPORT; RATS; RECEPTORS, NEUROTENSIN; TRANSFECTION;

MAMMALIA;

EID: 33846031539     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.062     Document Type: Article

References (47)

1. Bai M. Dimerization of G-protein-coupled receptors: roles in signal transduction. Cell Signal 16 (2004) 175-186
2. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev. Neurosci. 2 (2001) 274-286
3. Prinster S.C., Hague C., and Hall R.A. Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 57 (2005) 289-298
4. Lavoie C., Mercier J.F., Salahpour A., Umapathy D., Breit A., Villeneuve L.R., Zhu W.Z., Xiao R.P., Lakatta E.G., Bouvier M., and Hebert T.E. Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. J. Biol. Chem. 277 (2002) 35402-35410
5. Rocheville M., Lange D.C., Kumar U., Sasi R., Patel R.C., and Patel Y.C. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J. Biol. Chem. 275 (2000) 7862-7869
6. Tyler-McMahon B.M., Boules M., and Richelson E. Neurotensin: peptide for the next millennium. Regul. Pept. 93 (2000) 125-136
7. Vincent J.P., Mazella J., and Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol. Sci. 20 (1999) 302-309
8. Chalon P., Vita N., Kaghad M., Guillemot M., Bonnin J., Delpech B., Le Fur G., Ferrara P., and Caput D. Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett. 386 (1996) 91-94
9. Mazella J., Zsurger N., Navarro V., Chabry J., Kaghad M., Caput D., Ferrara P., Vita N., Gully D., Maffrand J.P., and Vincent J.P. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J. Biol. Chem. 273 (1998) 26273-26276
10. Tanaka K., Masu M., and Nakanishi S. Structure and functional expression of the cloned rat neurotensin receptor. Neuron 4 (1990) 847-854
11. Amar S., Mazella J., Checler F., Kitabgi P., and Vincent J.P. Regulation of cyclic GMP levels by neurotensin in neuroblastoma clone N1E115. Biochem. Biophys. Res. Commun. 129 (1985) 117-125
12. Watson M.A., Yamada M., Cusack B., Veverka K., Bolden-Watson C., and Richelson E. The rat neurotensin receptor expressed in Chinese hamster ovary cells mediates the release of inositol phosphates. J. Neurochem. 59 (1992) 1967-1970
13. Bozou J.C., Rochet N., Magnaldo I., Vincent J.P., and Kitabgi P. Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein. Biochem. J. 264 (1989) 871-878
14. Poinot-Chazel C., Portier M., Bouaboula M., Vita N., Pecceu F., Gully D., Monroe J.G., Maffrand J.P., Le Fur G., and Casellas P. Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24. Biochem. J. 320 Pt 1 (1996) 145-151
15. Botto J.M., Guillemare E., Vincent J.P., and Mazella J. Effects of SR 48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system: agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine insensitive neurotensin receptor. Neurosci. Lett. 223 (1997) 193-196
16. Gendron L., Perron A., Payet M.D., Gallo-Payet N., Sarret P., and Beaudet A. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2. Mol. Pharmacol. 66 (2004) 1421-1430
17. Sarret P., Gendron L., Kilian P., Nguyen H.M., Gallo-Payet N., Payet M.D., and Beaudet A. Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells. J. Biol. Chem. 277 (2002) 36233-36243
18. Hermans E., and Maloteaux J.M. Mechanisms of regulation of neurotensin receptors. Pharmacol. Ther. 79 (1998) 89-104
19. Vandenbulcke F., Nouel D., Vincent J.P., Mazella J., and Beaudet A. Ligand-induced internalization of neurotensin in transfected COS-7 cells: differential intracellular trafficking of ligand and receptor. J. Cell Sci. 113 Pt 17 (2000) 2963-2975
20. Botto J.M., Chabry J., Sarret P., Vincent J.P., and Mazella J. Stable expression of the mouse levocabastine-sensitive neurotensin receptor in HEK 293 cell line: binding properties, photoaffinity labeling, and internalization mechanism. Biochem. Biophys. Res. Commun. 243 (1998) 585-590
21. Perron A., Sharif N., Gendron L., Lavallee M., Stroh T., Mazella J., and Beaudet A. Sustained neurotensin exposure promotes cell surface recruitment of NTS2 receptors. Biochem. Biophys. Res. Commun. 343 (2006) 799-808
22. Martin S., Navarro V., Vincent J.P., and Mazella J. Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterology 123 (2002) 1135-1143
23. Boudin H., Pelaprat D., Rostene W., and Beaudet A. Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J. Comp. Neurol. 373 (1996) 76-89
24. Fassio A., Evans G., Grisshammer R., Bolam J.P., Mimmack M., and Emson P.C. Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody. Neuropharmacology 39 (2000) 1430-1442
25. Sarret P., and Beaudet A. Neurotensin receptors in the central nervous system, Handbook of chemical neuroanatomy. Peptide Receptors, Part II vol. 20 (2003), Elsevier, Amsterdam 323-400
26. Sarret P., Perron A., Stroh T., and Beaudet A. Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system. J. Comp. Neurol. 461 (2003) 520-538
27. Sarret P., Esdaile M.J., Perron A., Martinez J., Stroh T., and Beaudet A. Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors. J. Neurosci. 25 (2005) 8188-8196
28. Zhang X., Xu Z.Q., Bao L., Dagerlind A., and Hokfelt T. Complementary distribution of receptors for neurotensin and NPY in small neurons in rat lumbar DRGs and regulation of the receptors and peptides after peripheral axotomy. J. Neurosci. 15 (1995) 2733-2747
29. Labbe-Jullie C., Barroso S., Nicolas-Eteve D., Reversat J.L., Botto J.M., Mazella J., Bernassau J.M., and Kitabgi P. Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist. J. Biol. Chem. 273 (1998) 16351-16357
30. Donato di Paola E., Cusack B., Yamada M., and Richelson E. Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13). J. Pharmacol. Exp. Ther. 264 (1993) 1-5
31. Maggio R., Novi F., Scarselli M., and Corsini G.U. The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology. FEBS J. 272 (2005) 2939-2946
32. Terrillon S., and Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO Rep. 5 (2004) 30-34
33. Barki-Harrington L., Luttrell L.M., and Rockman H.A. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation 108 (2003) 1611-1618
34. Ciruela F., Escriche M., Burgueno J., Angulo E., Casado V., Soloviev M.M., Canela E.I., Mallol J., Chan W.Y., Lluis C., McIlhinney R.A., and Franco R. Metabotropic glutamate 1alpha and adenosine A1 receptors assemble into functionally interacting complexes. J. Biol. Chem. 276 (2001) 18345-18351
35. Gomes I., Jordan B.A., Gupta A., Trapaidze N., Nagy V., and Devi L.A. Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J. Neurosci. 20 (2000) RC110
36. Kunishima N., Shimada Y., Tsuji Y., Sato T., Yamamoto M., Kumasaka T., Nakanishi S., Jingami H., and Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407 (2000) 971-977
37. Romano C., Miller J.K., Hyrc K., Dikranian S., Mennerick S., Takeuchi Y., Goldberg M.P., and O'Malley K.L. Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu5 dimerization. Mol. Pharmacol. 59 (2001) 46-53
38. Zhang Z., Sun S., Quinn S.J., Brown E.M., and Bai M. The extracellular calcium-sensing receptor dimerizes through multiple types of intermolecular interactions. J. Biol. Chem. 276 (2001) 5316-5322
39. Zhu X., and Wess J. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 37 (1998) 15773-15784
40. Pagano A., Rovelli G., Mosbacher J., Lohmann T., Duthey B., Stauffer D., Ristig D., Schuler V., Meigel I., Lampert C., Stein T., Prezeau L., Blahos J., Pin J., Froestl W., Kuhn R., Heid J., Kaupmann K., and Bettler B. C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors. J. Neurosci. 21 (2001) 1189-1202
41. Tan C.M., Brady A.E., Nickols H.H., Wang Q., and Limbird L.E. Membrane trafficking of G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 559-609
42. Jordan B.A., Trapaidze N., Gomes I., Nivarthi R., and Devi L.A. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc. Natl. Acad. Sci. USA 98 (2001) 343-348
43. Souaze F., and Forgez P. Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulation. Peptides 27 (2006) 2493-2501
44. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53 (2001) 1-24
45. Toy-Miou-Leong M., Cortes C.L., Beaudet A., Rostene W., and Forgez P. Receptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation. J. Biol. Chem. 279 (2004) 12636-12646
46. Najimi M., Souaze F., Mendez M., Hermans E., Berbar T., Rostene W., and Forgez P. Activation of receptor gene transcription is required to maintain cell sensitization after agonist exposure. Study on neurotensin receptor. J. Biol. Chem. 273 (1998) 21634-21641
47. Souaze F., Rostene W., and Forgez P. Neurotensin agonist induces differential regulation of neurotensin receptor mRNA. Identification of distinct transcriptional and post-transcriptional mechanisms. J. Biol. Chem. 272 (1997) 10087-10094